PUBLIC COMPANY
saveShenzhen Evergreen Therapeutics Co Ltd
updated 2mo ago
community read0 votes
pipeline
9
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(9)
pipeline depth9 products
4Preclinical3Phase 12Phase 2
Phase 2
EG-007
Endometrial Cancer
Phase 2EG-501
Cognitive Impairment
Phase 1EG-001
Idiopathic Interstitial Pneumonia (IIP)
Phase 1EG-009
Coronavirus Disease 2019 (COVID-19) Associated Cytokine R…
Phase 1EG-301
Dry (Atrophic) Macular Degeneration
PreclinicalEG-102
Focal Segmental Glomerulosclerosis (FSGS)
PreclinicalEG-201
Wet (Neovascular / Exudative) Macular Degeneration
PreclinicalEG-401
Diabetic Retinopathy
PreclinicalEG-402
Retinopathy Of Prematurity
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that